MoneyWorks4Me

Venus Remedies - Quaterly Results

30 Jan 2023 Evaluate
A decrease in the sales to Rs. 1094.50 millions was observed for the quarter ended December 2022. The sales stood at Rs. 1174.40 millions during the similar quarter previous year.Net profit of the cmpany stood at Rs. 26.10 millions for the quarter ended December 2022 a decline of -66.75% from Rs. 78.50 millions  in the same quarter last year.Operating Profit reported a sharp decline to 108.30 millions from 153.00 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 1094.50 1174.40 -6.80 3891.30 4469.30 -12.93 5751.81 5146.23 11.77
Other Income 37.50 10.70 250.47 69.30 59.60 16.28 84.29 177.62 -52.54
PBIDT 108.30 153.00 -29.22 474.30 674.70 -29.70 772.50 646.25 19.54
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 127.26 -100.00
PBDT 108.30 153.00 -29.22 474.30 674.70 -29.70 772.50 753.41 2.53
Depreciation 69.70 84.00 -17.02 233.10 252.20 -7.57 325.80 342.80 -4.96
PBT 38.60 69.00 -44.06 241.20 422.50 -42.91 446.70 410.61 8.79
TAX 12.50 -9.50 -231.58 26.90 -43.19 -162.28 -43.16 -132.12 -67.33
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 26.10 78.50 -66.75 214.30 465.69 -53.98 489.86 542.73 -9.74
Equity 133.70 133.70 0.00 133.70 133.70 0.00 133.67 123.42 8.30
PBIDTM(%) 9.89 13.03 -24.05 12.19 15.10 -19.26 13.43 12.56 6.95
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1145.25
Cipla 1359.75
Lupin 2047.20
Zydus Lifesciences 1105.00
View more..